1. Home
  2. VABK vs MDWD Comparison

VABK vs MDWD Comparison

Compare VABK & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virginia National Bankshares Corporation

VABK

Virginia National Bankshares Corporation

N/A

Current Price

$42.60

Market Cap

231.3M

Sector

Finance

ML Signal

N/A

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$16.73

Market Cap

212.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
MDWD
Founded
1998
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
231.3M
212.1M
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
VABK
MDWD
Price
$42.60
$16.73
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$36.00
AVG Volume (30 Days)
4.4K
51.0K
Earning Date
04-23-2026
05-20-2026
Dividend Yield
3.39%
N/A
EPS Growth
12.70
N/A
EPS
0.97
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$48.92
Revenue Next Year
N/A
$35.04
P/E Ratio
$43.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.37
$14.90
52 Week High
$48.58
$22.51

Technical Indicators

Market Signals
Indicator
VABK
MDWD
Relative Strength Index (RSI) 53.12 47.69
Support Level $38.18 $16.26
Resistance Level $43.98 $18.38
Average True Range (ATR) 1.09 0.51
MACD -0.23 -0.03
Stochastic Oscillator 15.79 35.99

Price Performance

Historical Comparison
VABK
MDWD

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company engaged in commercial and retail banking. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts, and other depository services. Its segments include the Bank, VNB Trust and Estate Services, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits, and offering related services to individuals, businesses, and charitable organizations.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: